期刊
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
卷 1499, 期 1, 页码 3-17出版社
WILEY
DOI: 10.1111/nyas.14333
关键词
sepsis; myeloid; immunosuppression; immunodeficiency; HLA-DR; monocyte; MDSC
资金
- Hospices Civils de Lyon
Sepsis profoundly impacts immune homeostasis by disrupting myeloid cell response. This disruption includes mechanisms such as apoptosis, endotoxin tolerance, and metabolic failure, leading to increased risk of adverse outcomes in patients. Therapeutic strategies targeting these defects primarily involve the use of immunoadjuvant molecules.
On May 2017, the World Health Organization recognized sepsis as a global health priority. Sepsis profoundly perturbs immune homeostasis by initiating a complex response that varies over time, with the concomitant occurrence of pro- and anti-inflammatory mechanisms. Sepsis deeply impacts myeloid cell response. Different mechanisms are at play, such as apoptosis, endotoxin tolerance, metabolic failure, epigenetic reprogramming, and central regulation. This induces systemic effects on circulating immune cells and impacts progenitors locally in lymphoid organs. In the bone marrow, a progressive shift toward the release of immature myeloid cells (including myeloid-derived suppressor cells), at the expense of mature neutrophils, takes place. Circulating dendritic cell number remains dramatically low and monocytes/macrophages display an anti-inflammatory phenotype and reduced antigen presentation capacity. Intensity and persistence of these alterations are associated with increased risk of deleterious outcomes in patients. Thus, myeloid cells dysfunctions play a prominent role in the occurrence of sepsis-acquired immunodeficiency. For the most immunosuppressed patients, this paves the way for clinical trials evaluating immunoadjuvant molecules (granulocyte-macrophage colony-stimulating factor and interferon gamma) aimed at restoring homeostatic myeloid cell response. Our review offers a summary of sepsis-induced myeloid cell dysfunctions and current therapeutic strategies proposed to target these defects in patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据